Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.0%

4 terminated/withdrawn out of 25 trials

Success Rate

69.2%

-17.3% vs industry average

Late-Stage Pipeline

20%

5 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
12(52.2%)
Phase 3
4(17.4%)
N/A
3(13.0%)
Phase 1
3(13.0%)
Phase 4
1(4.3%)
23Total
Phase 2(12)
Phase 3(4)
N/A(3)
Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials
NCT07565324Phase 2Not Yet Recruiting

Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)

Role: collaborator

NCT06966284Recruiting

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

Role: lead

NCT04999332Phase 2Unknown

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

Role: collaborator

NCT05359627Phase 1Completed

A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency

Role: lead

NCT04070313Phase 2Terminated

A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan

Role: lead

NCT01210768Phase 2Unknown

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Role: lead

NCT04377048Phase 2Unknown

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

Role: collaborator

NCT02425137Phase 2Completed

A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer

Role: lead

NCT03669263Not ApplicableCompleted

A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan

Role: collaborator

NCT03517618Phase 2Completed

TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC

Role: lead

NCT03511820Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

Role: lead

NCT03316326Phase 2Unknown

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

Role: collaborator

NCT02980653Phase 2Unknown

Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT

Role: lead

NCT01946646Phase 1Terminated

Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer

Role: collaborator

NCT02761291Phase 1Unknown

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT01874678Not ApplicableCompleted

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

Role: lead

NCT01450748Phase 3Completed

Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux

Role: lead

NCT02277886Phase 4Unknown

Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances

Role: collaborator

NCT02136030Not ApplicableUnknown

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

Role: lead

NCT01188265Phase 3Completed

Add-on Dextromethorphan in Bipolar Disorders

Role: collaborator